Ara
Toplam kayıt 6, listelenen: 1-6
QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results
(Clinical Rheumatology, 2020-10-15)
Objectives The Turkish population is vaccinated with Bacille Calmette-Guérin (BCG), and the BCG vaccination decreases the specificity of the tuberculin skin test (TST). The purpose of this study was to investigate the ...
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
(TÜBİTAK, 2020-02-13)
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...
Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-α biologics: real-life results from a single-centre cross-sectional study
(Springer, 2020-01-28)
Abstract
Most patients with inflammatory arthritis are at their reproductive ages. Use of anti-tumour necrosis factor alpha (anti-TNF-α) agents, one of the important treatment options for inflammatory arthritis, can ...
Imaging Modalities Used in Diagnosis and Follow-Up of Patients with Takayasu’s Arteritis
(Turk J Med SciTÜBİTAK, 2021-02-26)
Background/aim: Takayasu’s arteritis (TA) is a rare, large-vessel vasculitis of unknown etiology, affecting aortic arch, and its main branches. Noninvasive imaging methods are frequently used in diagnosis and follow-up in ...
Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients
(Oxford Univ Press, 2020-06-01)
Objectives: FMF is the most common periodic fever syndrome, characterized by recurrent episodes of fever and serosal inflammation accompanied with high acute phase reactants. The analysis of possible comorbidities is ...
Covid-19 Pandemi Raporu (20 Mart-20 Kasım 2020)
(Hacettepe İç Hastalıkları Derneği, 2021)
31 Aralık 2019 tarihinde Çin’de ortaya çıkan ve kısa sürede tüm dünyayı
etkileyen SARS-Coronavirus-2 etkenine bağlı COVID-19’un Dünya Sağlık Örgütü
tarafından pandemi ilan edildiği dönem ile eş zamanlı olarak, ülkemizde ...